Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Stimulating either of a pair of crucial nerves that carry messages from the brain to several major organs could be an ...

Those on the extreme end of the depression spectrum face symptoms that impact their daily activities too and not just their ...

Providers, patients and even some federal judges say progress-based insurance denials harm patients at key moments of mental ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

The clinical-stage biopharmaceutical company said the Phase 3 study didn't demonstrate a statistically significant improvement on the primary endpoint of change from baseline in a scale that measures ...

The treatment of mood disorders and chronic pain conditions is a difficult undertaking. If you’ve already explored various ...

Professor Raz Yirmiya’s research connects stress, inflammation, and depression, uncovering potential new treatments for ...

The study observed that self-reflection and positive approach can help in improving the symptoms of depression ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

The legalization of “magic” mushrooms comes as people increasingly turn to psychedelics to treat anxiety, depression and ...

People explore different treatments and therapies to help with depression, and recently, researchers wanted to understand if ...